1. Downregulation of CXCR1 ameliorates experimental colitis: evidence for CXCL1-CXCR1-mediated immune cell recruitment.
- Author
-
Becker, Felix, Holthoff, Christina, Anthoni, Christoph, Rijcken, Emile, Alexander, J., Gavins, Felicity, Spiegel, HU, Senninger, Norbert, and Vowinkel, Thorsten
- Subjects
- *
CHEMOKINE receptors , *COLITIS treatment , *INFLAMMATORY bowel diseases , *CHEMOTAXIS , *LABORATORY mice - Abstract
Purpose: Inflammatory conditions like inflammatory bowel diseases (IBD) are characterized by increased immune cell infiltration. The chemokine ligand CXCL1 and its receptor CXCR1 have been shown to be involved in leukocyte adhesion, transendothelial recruitment, and chemotaxis. Therefore, the objective of this study was to describe CX3CL1-CX3CR1-mediated signaling in the induction of immune cell recruitment during experimental murine colitis. Methods: Acute colitis was induced by dextran sodium sulfate (DSS), and sepsis was induced by injection of lipopolysaccharide (LPS). Serum concentrations of CXCR1 and CXCL1 were measured by ELISA. Wild-type and CXCR1 mice were challenged with DSS, and on day 6, intravital microscopy was performed to monitor colonic leukocyte and platelet recruitment. Intestinal inflammation was assessed by disease activity, histopathology, and neutrophil infiltration. Results: CXCR1 was upregulated in DSS colitis and LPS-induced sepsis. CXCR1 mice were protected from disease severity and intestinal injury in DSS colitis, and CXCR1 deficiency resulted in reduced rolling of leukocytes and platelets. Conclusions: In the present study, we provide evidence for a crucial role of CXCL1-CXCR1 in experimental colitis, in particular for intestinal leukocyte recruitment during murine colitis. Our findings suggest that CXCR1 blockade represents a potential therapeutic strategy for treatment of IBD. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF